Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Cytomegalovirus reactivation in multiple myeloma patients receiving bispecific antibodies — Enric Sastre (2026) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Cytomegalovirus reactivation in multiple myeloma patients receiving bispecific antibodies
Shared by
Amit Khot
University of Melbourne
Cytomegalovirus reactivation in multiple myeloma patients receiving bispecific antibodies
Article
2026
en
Authors
+5 more
ES
Enric Sastre
GR
Gemma K Reynolds
MY
Michelle K Yong
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2016
Emerging antibodies for the treatment of multiple myeloma
Flora Zagouri
,
Evangelos Terpos
,
Efstathios Kastritis
,
Meletios A Dimopoulos
Article
2019
Anti-BCMA antibodies in the future management of multiple myeloma
Maria Gavriatopoulou
,
Ioannis Ntanasis‐Stathopoulos
,
Meletios A Dimopoulos
,
Evangelos Terpos
Article
2006
Survival in patients with multiple myeloma receiving zoledronic acid: Stratification by baseline bone alkaline phosphatase levels
James R. Berenson
,
N. Shirina
,
Y. M. Chen
,
Meletios A Dimopoulos
Letter
2012
Disease reactivation after fingolimod discontinuation in two multiple sclerosis patients
Angelo Ghezzi
,
Maria A. Rocca
,
Damiano Baroncini
,
Pietro Annovazzi
,
Mauro Zaffaroni
,
G. Minonzio
,
Gıancarlo Comı
,
Massimo Filippi
Article
2025
Burden and characteristics of infections in patients treated with bispecific antibodies and the impact of immunoglobulin replacement
Efstathios Kastritis
,
Eirini Solia
,
Ilias Katsadouros
,
Panagiotis Malandrakis
,
Ioannis Ntanasis‐Stathopoulos
,
Foteini Theodorakakou
,
Nikolaos Kanellias
,
Evangelos Eleutherakis Papaiakovou
,
Magdalini Migkou
,
Vasiliki Spiliopoulou
,
Despina Fotiou
,
Maria Gavriatopoulou
,
Evangelos Terpos
,
Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.